COMPPARE Newsletter: Summer 2025

connection


Dr. Nancy Mendenhall

A Message from Dr. Nancy Mendenhall

In this issue, we invite you to delve further into the importance of our Primary Completion Date (PCD) on February 15, 2026. As we look ahead to this milestone, we also recognize the vital role each participant plays in helping to generate trustworthy, patient-informed results on disease control, side effects, and quality of life. These findings will not only guide physicians and policymakers but also empower future patients to make more informed decisions. Read Dr. Mendenhall’s message.

 

 

 


Vertical Flow ChartThe Importance of the Primary Completion Date

When you volunteered for COMPPARE, you might have heard about something its PCD. But what does that mean for you, really? The PCD for COMPPARE is the date when all participants have finished 3 years of follow-up after radiation therapy and our key aims can now be analyzed and reported on – delve into the PCD details here.

 

 

 

 


Why your participation mattersWhy Your Participation in COMPPARE Matters More than Ever

COMPPARE has become a national model for inclusive, patient-centered research, especially through its strong minority enrollment. Its results may influence how physicians counsel patients, how treatment is delivered, and how insurers provide coverage for advanced options like proton therapy.  Understand why your contributions are so important in the years to come.

 


Prostate cancer scansA Better Alternative to MRI for Prostate Cancer Biopsies?

The growing role of PSMA PET/CT scans has been touted as a breakthrough tool for spotting prostate cancers that MRI-guided biopsies can miss. Now, another option is emerging as a valuable alternative in prostate cancer diagnosis – read more about this important finding.

 


Research reported in this newsletter was partially funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (PCS-2017C1-0422). The views, statements, and opinions presented in this newsletter are solely the responsibility of the authors and do not necessarily represent the views of PCORI, its Board of Governors, or Methodology Committee.


Archive

We look forward to sharing our patient-centric news with you. Below you can find an archive of our issues and subscribe to receive COMPPARE Connection in your inbox.


COMPPARE Newsletter Subscription